Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Notification of Proposed Production Activity; MSD International GMBH (Puerto Rico Branch) LLC; Subzone 7G (Pharmaceuticals) Las Piedras, Puerto Rico, 64131 [2016-22480]

Download as PDF Federal Register / Vol. 81, No. 181 / Monday, September 19, 2016 / Notices Commission, grantee of FTZ 119, submitted a notification of proposed production activity to the FTZ Board on behalf of Sick, Inc., within Subzone 119G, in Savage, Minnesota. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (81 FR 37570, June 10, 2016). The FTZ Board has determined that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the Board’s regulations, including Section 400.14. Dated: September 13, 2016. Andrew McGilvray, Executive Secretary. [FR Doc. 2016–22399 Filed 9–16–16; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–60–2016] mstockstill on DSK3G9T082PROD with NOTICES Foreign-Trade Zone (FTZ) 7— Mayaguez, Puerto Rico; Notification of Proposed Production Activity; MSD International GMBH (Puerto Rico Branch) LLC; Subzone 7G (Pharmaceuticals) Las Piedras, Puerto Rico MSD International GMBH (Puerto Rico Branch) LLC (MSD), operator of Subzone 7G, submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 7G, in Las Piedras, Puerto Rico. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on August 29, 2016. MSD currently has authority to produce certain pharmaceutical products and their intermediates within Subzone 7G. The current request would add a finished pharmaceutical product and foreign status materials/components to the scope of authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited to the specific foreignstatus materials/components and specific finished product described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt MSD from customs duty payments on the foreign-status materials/components used in export production. On its domestic sales, MSD would be able to choose the duty rate during customs entry procedures that VerDate Sep<11>2014 21:47 Sep 16, 2016 Jkt 238001 applies to finished ertugliflozin/ metformin pharmaceutical tablets for the treatment of type-2 diabetes (duty free) for the foreign-status materials/ components noted below and in the existing scope of authority. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The materials/components sourced from abroad include: Metformin hydrochloride and jet-milled ertugliflozin active ingredients (duty rates 3.7% and 6.5%). Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is October 31, 2016. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Diane Finver at Diane.Finver@trade.gov or (202) 482–1367. Dated: September 13, 2016. Andrew McGilvray, Executive Secretary. [FR Doc. 2016–22480 Filed 9–16–16; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE International Trade Administration [A–552–801] Certain Frozen Fish Fillets From the Socialist Republic of Vietnam: Preliminary Results and Partial Rescission of the Antidumping Duty Administrative Review; 2014–2015 Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The Department preliminarily determines that none of the mandatory respondents in this review qualify for a separate rate and are, therefore, considered a part of the Vietnam-Wide Entity for their exports of subject merchandise exported to the United States during the period of review (‘‘POR’’) August 1, 2014, through July 31, 2015. If these preliminary results are adopted in the final results, the Department will instruct U.S. Customs and Border Protection (‘‘CBP’’) to assess antidumping duties on all appropriate AGENCY: PO 00000 Frm 00006 Fmt 4703 Sfmt 4703 64131 entries of subject merchandise during the POR. Interested parties are invited to comment on these preliminary results. DATES: Effective September 19, 2016. FOR FURTHER INFORMATION CONTACT: Kenneth Hawkins or Javier Barrientos, AD/CVD Operations, Office V, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue NW., Washington, DC 20230; telephone 202– 482–6491 or 202–482–2243, respectively. SUPPLEMENTARY INFORMATION: Background On September 30, 2014, the Department initiated the 12th administrative review of the antidumping duty order on fish fillets from Vietnam for the period August 1, 2014, through July 31, 2015.1 On May 4, 2016, the Department partially extended the deadline for issuing the preliminary results by 118 days.2 The revised deadline for the preliminary results of this administrative review is now September 6, 2016. Scope of the Order The product covered by the order is frozen fish fillets, including regular, shank, and strip fillets and portions thereof, whether or not breaded or marinated, of the species Pangasius Bocourti, Pangasius Hypophthalmus (also known as Pangasius Pangasius) and Pangasius Micronemus. These products are classifiable under tariff article code 0304.62.0020 (Frozen Fish Fillets of the species Pangasius, including basa and tra), and may enter under tariff article codes 0305.59.0000, 1604.19.2100, 1604.19.3100, 1604.19.4100, 1604.19.5100, 1604.19.6100 and 1604.19.8100 of the Harmonized Tariff Schedule of the United States (‘‘HTSUS’’).3 Although 1 See Initiation of Antidumping and Countervailing Duty Administrative Reviews, 80 FR 60356 (October 6, 2015). 2 See Memorandum to Christian Marsh, Deputy Assistant Secretary, Antidumping and Countervailing Duty Operations, through James C. Doyle, Director, Office V, Antidumping and Countervailing Duty Operations regarding, from, Kenneth Hawkins, International Trade Compliance Analyst, Antidumping and Countervailing Duty Operations, ‘‘Certain Frozen Fish Fillets from the Socialist Republic of Vietnam: Extension of Deadline for Preliminary Results of 2014–2015 Antidumping Duty Administrative Review,’’ dated May 4, 2016. 3 Until June 30, 2004 these products were classifiable under HTSUS 0304.20.6030, 0304.20.6096, 0304.20.6043 and 0304.20.6057. From July 1, 2004 until December 31, 2006 these products were classifiable under HTSUS 0304.20.6033. From January 1, 2007 until December E:\FR\FM\19SEN1.SGM Continued 19SEN1

Agencies

[Federal Register Volume 81, Number 181 (Monday, September 19, 2016)]
[Notices]
[Page 64131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22480]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-60-2016]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Notification 
of Proposed Production Activity; MSD International GMBH (Puerto Rico 
Branch) LLC; Subzone 7G (Pharmaceuticals) Las Piedras, Puerto Rico

    MSD International GMBH (Puerto Rico Branch) LLC (MSD), operator of 
Subzone 7G, submitted a notification of proposed production activity to 
the FTZ Board for its facility within Subzone 7G, in Las Piedras, 
Puerto Rico. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on August 29, 
2016.
    MSD currently has authority to produce certain pharmaceutical 
products and their intermediates within Subzone 7G. The current request 
would add a finished pharmaceutical product and foreign status 
materials/components to the scope of authority. Pursuant to 15 CFR 
400.14(b), additional FTZ authority would be limited to the specific 
foreign-status materials/components and specific finished product 
described in the submitted notification (as described below) and 
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt MSD from customs duty 
payments on the foreign-status materials/components used in export 
production. On its domestic sales, MSD would be able to choose the duty 
rate during customs entry procedures that applies to finished 
ertugliflozin/metformin pharmaceutical tablets for the treatment of 
type-2 diabetes (duty free) for the foreign-status materials/components 
noted below and in the existing scope of authority. Customs duties also 
could possibly be deferred or reduced on foreign-status production 
equipment.
    The materials/components sourced from abroad include: Metformin 
hydrochloride and jet-milled ertugliflozin active ingredients (duty 
rates 3.7% and 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary at the 
address below. The closing period for their receipt is October 31, 
2016.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
Diane.Finver@trade.gov or (202) 482-1367.

    Dated: September 13, 2016.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2016-22480 Filed 9-16-16; 8:45 am]
 BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.